Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
GSK PLC ADR
ISIN US37733W2044
|WKN A3DMHS
Market cap (in EUR)
85,016 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
3.42%
Advertisement
Capital at risk. Execution-only service.
Overview
Description
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United Kingdom
Financials
Key metrics
| Market capitalisation, EUR | 85,016 m |
| EPS, EUR | 3.22 |
| P/B ratio | 4.5 |
| P/E ratio | 13.6 |
| Dividend yield | 3.42% |
Income statement (2024)
| Revenue, EUR | 37,065 m |
| Net income, EUR | 3,042 m |
| Profit margin | 8.21% |
What ETF is GSK PLC ADR in?
There are 2 ETFs which contain GSK PLC ADR. All of these ETFs are listed in the table below. The ETF with the largest weighting of GSK PLC ADR is the Fidelity US Fundamental Large Cap Core UCITS ETF ACC-USD.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| First Trust Value Line® Dividend Index UCITS ETF Acc | 0.46% | Equity United States Dividend | 5 |
| Fidelity US Fundamental Large Cap Core UCITS ETF ACC-USD | 0.90% | Equity United States Large Cap | 23 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.